Here’s Why You Should Retain Allscripts (MDRX) Stock For Now

Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust second-quarter 2021 performance, along with various innovation milestones, is expected to contribute further. However, healthcare regulatory changes and foreign exchange concerns persist. Over the past year, this Zacks Rank #3 (Hold) stock […]

Read More…

CareMetx Partners with Emerging Therapy Solutions (ETS) to Address High Cost of Therapy for Rare Genetic Diseases

CareMetx’s subsidiary OutcomeRx Insurance Management Services,LLC will leverage access to the Emerging Therapy Solutions (ETS) nationwide network of over 120 medical centers, in order to bolster their Patient Access to Costly and Curative Therapies (PACCT) product, one designed to help payers manage the sudden, high costs of therapies for rare genetic diseases. Bethesda, MD, Nov. […]

Read More…

Veradigm Partners with CareMetx, LLC to Optimize End-to-End Specialty Medication Access and Services Streamlining Patient Care

New Strategic Partnership Will Simplify and Accelerate Specialty Approval Medication Process CHICAGO – OCTOBER 5, 2021 — Veradigm®, a leading provider of healthcare data and technology solutions a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today a new […]

Read More…

CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company

CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company The acquisition of Phyz Healthcare Solutions offers clients exposure to an expanded network of providers by embedding access to specialty therapies directly into the prescriber workflow. CareMetx, a leading technology-enabled hub services company […]

Read More…

CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership

CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership  Significant investment from General Atlantic and The Vistria Group positions CareMetx for continued growth in supporting patient access to innovative therapies Bethesda, MD, New York, NY and Chicago, IL – January 14, 2021 […]

Read More…

OutcomeRx, a division of CareMetx, LLC announces First Independent Reinsurance Product for Rare Disease Specialty, Cell and Gene Therapies

Launch of new reinsurance product will help payers manage sudden, high costs of therapies for rare genetic diseases with goal of reducing access and affordability challenges for patients Bethesda, MD (October 28, 2020) – OutcomeRx (ORx), a division of CareMetx, LLC, announced today a new reinsurance product to provide coverage access to high-cost specialty drugs […]

Read More…